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ABSTRACTS

formation. Presenting symptoms were; urethral discharge 37(92.5%), pelvic pain/bladder spasms 23(57.5%),
acute infection/sepsis 12 (30%) and haematuria 1(2.5%).
Aetiology for conduit and pyocystis is detailed in Table 1.
Prior bladder augmentation was a significant risk
factor for the development of pyocystis. Pyocystis treatment and resolution rates are detailed in Table 2.
Conclusion: Pyocystis develops in 37.7% following
ileal conduit formation. Previous bladder augmentation
is a significant risk factor for its development. Conservative measures are successful in treating 40% of cases
whilst simple cystectomy is required in 60%.

Funding: N/A

#M47 | CHANGES IN PATIENT
REPORTED OUTCOME MEASURES
AFTER TREATMENT OF FEMALE
URETHRAL STRICTURE
Alyssa Gracely1, Giulia I. Lane1, Pansy Uberoi2, Una Lee2,
Ariana Smith3, Jennifer Anger4, Didi Theva5, Jessica
DeLong6, Casey Kowalik7, Priya Padmanabhan8, Charles
Powell9, Maude Carmel10, J. Quentin Clemens1, Anne P.
Cameron1, Priyanka Gupta1
1

Dept. of Urology, University of Michigan, Ann Arbor, MI, 2Section of
Urology and Renal Transplantation, Virginia Mason Medical Center,
Seattle, WA, 3Dept. of Urology, Penn Medicine, Philadelphia, PA,
4
Division of Urology, Cedars‐Sinai Medical Center, Beverly Hills, CA,

S137

5

Memorial Hospital Miramar, Miramar, FL, 6Eastern Virginia Medical
School, Norfolk, VA, 7Kansas University Medical Center, Kansas City, KS,
8
Beaumont Hospital, Royal Oak, MI, 9Indiana University, Indianapolis,
IN, 10University of Texas Southwestern Medical Center, Dallas, TX

Presented By: Alyssa Kay Gracely, MD
Introduction: There is a paucity of patient reported
outcome measures (PROM) data for women with urethral strictures. Prior literature focuses on anatomic
success, with almost no data describing patient centered
outcomes. To fill this critical gap, we aim to evaluate
change in PROM among women who underwent surgery
for stricture.
Methods: Data were collected as part of a multi‐
institutional retrospective cohort study of women treated
for urethral stricture between 2010‐19. Median change
between baseline and postoperative follow‐up on the
American Urological Association Symptom Index (AUA‐
SI) and Urinary Distress Inventory (UDI‐6) were assessed
using paired Wilcoxon signed‐rank tests.
Results: Of the 210 women in the dataset, 57 had
AUA‐SS or UDI‐6 scores and 26 had both baseline and
post‐operative data for either measure. Median follow‐up
time was 21 months (IQR 7, 37). The majority of women
with complete PROM data underwent urethroplasty
(77%) and strictures did not recur (73%).
The median AUA‐SI was 21 (IQR 12, 28; n=39) at
baseline and 10 (IQR 5,24; n=33) at follow‐up. Among 18
patients with complete data, there was a median decrease
12 (IQR ‐18,‐2) points in AUA‐SI (p=0.003). This change
represents a clinically significant improvement in
symptom severity from severe to moderate. The median
AUA quality of life (QOL) score was 6 (IQR 4,6; n=36) at
baseline and 3 (IQR 2,5; n = 30) at follow‐up. Among 15
patients with complete data, there was a median improvement of 2 points (‐5,0; p=0.007) on the AUA QOL
score, indicating a shift from “unhappy” to “mixed.”
(Table) Median UDI‐6 scores were 50 (IQR 33,75; n=20)
and 17 (IQR 0, 39; n=15), at baseline and follow‐up, respectively. There was a median decrease of 19 points (‐31,
‐11; p=0.01, n=8), which achieved statistical and clinical
significance. (Table) There was no difference in change
in PROM between surgery type nor based on recurrence.
Conclusion: Women with urethral strictures have
severe lower urinary tract symptoms at baseline which
improved significantly after surgery. These findings,
though limited, represent some of the most robust data
on PROM for women with urethral stricture disease. This
study also underscores the importance of ongoing efforts
to integrate PROM into routine urologic practice.
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Introduction: Bladder neck contracture (BNC) associated with Stress Urinary Incontinence (SUI) is a
major complication of prostate cancer treatment. Clinicians are often hesitant to offer geriatric patients curative treatment for such complex complications. We report
the outcome of our approach using a two‐stage management of BNC associated with SUI after prostate cancer treatment in the geriatric population.
Methods: Data from 100 consecutive patients who underwent Artificial Urinary Sphincter (AUS) were reviewed
from April 2012 to August 2020. Patients age>65 were assigned to the Geriatric Subpopulation. 25 patients identified
(65 to 88 years, Mean age=76) with Post Radical Retropubic
Prostatectomy (RRP) or External Beam Radiation (XRT)
induced BNC associated with SUI elected to undergo our
two‐stage management. Stage I: Deep Transurethral Incision
for Bladder Neck Contracture (TUIBNC) with Collin's Hot
knife. Stage II: Bulbar urethra AUS implantation (AMS‐800),
6‐8 weeks after TUIBNC, once bladder neck patency had
been demonstrated cystoscopically.
Results: A 96 month study, mean follow up 48.5 months.
25 patients who met geriatric criteria underwent our two‐
staged approach of TUIBNC followed by AUS. Prostate
cancer treatment consisted of RRP in 10 patients, XRT in 8
patients, and a combination of RRP and XRT in 7 patients.
18 patients required only one TUIBNC pre AUS Implant, 6
patients required two, and another three patients TUIBNC
prior to AUS implant. One patient required TUIBNC after
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AUS implant Mean FU 48.5 Months. Complications included: AUS cuff erosion (4), Infected device (2), unable to
use AUS due to deteriorating manual dexterity (2), continued leakage associated with cuff atrophy (4). 18/25 (72%)
of patients are socially continent using less or equal to 1 pad/
day and happy with the device. Urinary Distress Inventory
(UDI‐6) administered pre and post AUS was statistically
significant (p <0.05). All (100%) patients would recommend
this approach to their friends and relatives on questionnaire.
Conclusion: Our data indicates that even in very
complex incontinent patients with XRT and RRP recurrent BNC, the two‐stage approach provides a good
outcome with minimal morbidity in a difficult cohort of
patients. Chronologic age alone should not deter from
AUS placement because many geriatric patients are
highly motivated to receive curative treatment of their
urinary incontinence.
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Introduction: Transgender individuals may elect to
undergo genital reconstructive surgery (GRS). While it is
generally agreed that all patients must meet the requirements set out in the World Professional Association
for Transgender Health (WPATH) standards of care,
some physicians also restrict eligibility for surgery based
on a patient's weight or body mass index (BMI). In our
experience with gender‐affirming vaginoplasty, we have
not utilized a BMI cut‐off. In this report, we explore the
impact of BMI on the risk of complications following
GRS by comparing the outcomes of obese and non‐obese
patients undergoing either penile inversion vaginoplasty
or robotic‐assisted peritoneal flap vaginoplasty.
Methods: A prospective cohort of all gender‐
affirming vaginoplasties in our practice between

